MSB 1.10% 91.5¢ mesoblast limited

A bit more on the FDA, page-56

  1. 521 Posts.
    lightbulb Created with Sketch. 1481
    @aatisket.

    My reply was in relation to correcting Tunas claim that contractually TEVA could only walk based on one(1) sole reason/basis. There were three(3) reason / basis ..as written in the 24/9/13 agreement.

    The fact is we don't know which one it was...forget about hypothesizing...If you know - x-reference your view to an actual TEVA/MSB release. If the answer was surrogates - this could ONLY have been performed by "the Statistician" - I'm not making this up , please read the agreement.

    If the statistician conducted such a review and gave notice to MSB / TEVA - this would have to be reported to ASX / Nasdaq . No such notice was ever given to ASX / Nasdaq.

    Make up your own view about CHF / P3 ..I've made up mine.

    All the best.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.